Sjs Investment Consulting Inc. Bristol Myers Squibb CO Transaction History
Sjs Investment Consulting Inc.
- $540 Million
- Q4 2024
A detailed history of Sjs Investment Consulting Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 1,052 shares of BMY stock, worth $60,363. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,052
Previous 1,005
4.68%
Holding current value
$60,363
Previous $52,000
13.46%
% of portfolio
0.01%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding BMY
# of Institutions
2,753Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.9 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.1 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.51 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.46 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.46 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $122B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...